Applied Aerospace & Defense offers exposure to growing defense, space and precision-strike spending through a business still very early in its public-market story. x.com 

SpaceX's projected growth is challenging the earlier overvaluation case, though the reassessment is still in progress. A VJN.ai chart projects revenue 273.3% higher by Q4 2027, even as the company is valued at $2 trillion. x.com  x.com 

SpaceX's strong earnings give its bullish setup fresh fundamental support. Revenue of $14.58 billion, adjusted EBITDA of $8.81 billion and operating income of $2.79 billion beat expectations, as did connectivity and space revenue; 35 launches and mass to orbit fell short. The shares are also pushing through a cup-and-handle breakout. x.com  x.com 

Doncasters' earnings look relatively certain over the next three years, making the stock look quite cheap. Aerospace jitters center on JBLU and Elon Musk entering the blades and vanes market, but SpaceX might supply only its own needs and has no chance of external sales until 2031 or later. x.com 

LightPath's production-scale drone-optics order signals further demand as the industry shifts from germanium. The order is now estimated at $15M-17.5M based on program economics, down from an initial $20M-plus estimate; the customer remains unconfirmed after an initial Anduril guess. Rubin and Miranda's 2.975M options at a $10.53 strike vest on a buyout, making $7-$9 bids unattractive; a meaningful payout needs a price in the mid-teens or $20s. More orders are expected. x.com  x.com  x.com  x.com  … Show more

Rocket Lab's defense contracts and backlog position it to benefit from national-security spending. Its $2.36B backlog includes over 100 booked launches, with an $816M SDA satellite deal and a $266M Space Force HASTE deal for hypersonic testing. Despite the Neutron delay, its $36B valuation offers one of the space sector's best risk-reward setups: exposure to the same defense and space-infrastructure trend as SpaceX at a fraction of its valuation. Rocket Lab is headed above $100. x.com 

SpaceX's AI spending is producing much more compute revenue without a comparable rise in capex, supporting its Overweight rating and $214 target. AI compute brought in about $7.6B versus $2.6B last quarter and ~$6.4B expected, while capex was $19.59B, in line with estimates. But cash of $51.29B versus $91.2B expected raises funding questions, and launches missed estimates. x.com  x.com  x.com  x.com 

Lockheed Martin looks like a really great opportunity in defense, with orders outpacing deliveries at a reasonable valuation. Its backlog is a record $230B, almost 3x expected 2026 revenue, after $65B of new Q2 orders. Q2 sales grew 11% to $20.1B, and management raised free cash flow guidance to over $7B for 2026. It trades at about 18-19x 2026 earnings, reasonable for a sector leader; the next few weeks are about finding an entry point. x.com 

SpaceX's Q3 profitability lets it fund much more of its buildout, significantly reducing the need for outside financing. Revenue of $14.6B and adjusted EBITDA of $8.8B beat even the high cases; free cash flow was still -$10B after $19.6B of capex. SpaceX said new compute deals price a bit above $30-$50 per watt with payback under a year, though Q4 capex is guided to $35-$40B. Starlink subscribers fell just short of the low case but beat the Street, and consumer revenue grew 26%. x.com  x.com  … Show more

Curtiss-Wright, an aerospace, defense and commercial nuclear supplier, is expensive against its earnings. At $545.79 it trades at 38 times earnings and 32 times next year's, versus the roughly 24 times aerospace and defense suppliers usually get. Fair value is $361.97 to $460.69, 24 times next year's $17.14 per share give or take 12%, putting the stock 18% above the high end; it is expensive above $582.72. This is a valuation-only view based on reported earnings and estimates. x.com